VEGF-C signaling pathways through VEGFR-2 and VEGFR-3 in vasculoangiogenesis and hematopoiesis

Blood

Volumn 96, Issue 12, 2000, Pages 3793-3800

  Hamada, K ^a   Oike, Y ^a   Takakura, N ^a   Ito, Y ^a   Jussila, L ^a   Dumont, D J ^a   Alitalo, K ^a   Suda, T ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; MUTANT PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3;

ANGIOGENESIS; ANIMAL CELL; AORTA; ARTICLE; CELL CULTURE; CLINICAL PATHWAY; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; HEMATOPOIESIS; MESODERM; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STROMA CELL;

EID: 0034554844     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.12.3793     Document Type: Article

References (40)

1. Mechanisms of angiogenesis
2. Signaling vascular morphogenesis and maintenance
3. Endothelial receptor tyrosine kinases involved in angiogenesis
4. Signaling angiogenesis and lymphangiogenesis
5. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development
6. The role of vascular endothelial growth factor in blood vessel formation
7. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
8. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
9. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
10. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
11. Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells
12. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases
13. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development
14. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)
15. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases
16. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development
17. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice
18. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3
19. Critical role of the TIE2 endothelial cell receptor in the development of definitive hematopoiesis
20. Vascular endothelial growth factor C induces angiogenesis in vivo
21. Expressions of PDGF receptor alpha, c-Kit and Flk1 genes clustering in mouse chromosome 5 define distinct subsets of nascent mesodermal cells
22. Two human FLT4 receptor tyrosine kinase isoforms with distinct carboxy terminal tails are produced by alternative processing of primary transcripts
23. Maturation of embryonic stem cells into endothelial cells in an in vitro model of vasculogenesis
24. Expression and function of murine receptor tyrosine kinases, TIE and TEK, in hematopoietic stem cells
25. Use of E. coli LacZ (betagalactosidase) as a reporter gene
26. Generation of lymphohematopoietic cells from embryonic stem cells in culture
27. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis
28. Vascularization of the mouse embryo: A study of flk-1, tek, tie, and vascular endothelial growth factor expression during development
29. Avian VEGF-C: Cloning, embryonic expression pattern and stimulation of the differentiation of VEGFR2-expressing endothelial cell precursors
30. Ligand-dependent development of the endothelial and hemopoietic lineages from embryonic mesodermal cells expressing vascular endothelial growth factor receptor 2
31. Proteolytic processing regulates receptor specificity and activity of VEGF-C
32. Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice
33. Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors: Generation of receptor-selective VEGF variants by site-directed mutagenesis
34. Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity
35. An early pre-liver intraembryonic source of CFU-S in the developing mouse
36. Development of hematopoietic stem cell activity in the mouse embryo
37. Definitive hematopoiesis is autonomously initiated by the AGM region
38. A common precursor for primitive erythropoiesis and definitive haematopoiesis
39. In vitro generation of lymphohematopoietic cells from endothelial cells purified from murine embryos
40. In vitro hematopoietic and endothelial cell development from cells expressing TEK receptor in murine aorta-gonad-mesonephros region